BACKGROUND: Despite the importance of timely management of patients with inflammatory arthritis (IA), delays exist in its diagnosis and treatment. OBJECTIVE: To perform a systematic literature review to identify strategies addressing these delays to inform an American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) taskforce. METHODS: The authors searched literature published between January 1985 and November 2010, and ACR and EULAR abstracts between 2007-2010. Additional information was obtained through a grey literature search, a survey conducted through ACR and EULAR, and a hand search of the literature. RESULTS: (1) From symptom onset to primary care, community case-finding strategies, including the use of a questionnaire and autoantibody testing, have been designed to identify patients with early IA. Several websites provided information on IA but were of varying quality and insufficient to aid early referral. (2) At a primary care level, education programmes and patient self-administered questionnaires identified patients with potential IA for referral to rheumatology. Many guidelines emphasised the need for early referral with one providing specific referral criteria. (3) Once referred, early arthritis clinics provided a point of early access for rheumatology assessment. Triage systems, including triage clinics, helped prioritise clinic appointments for patients with IA. Use of referral forms standardised information required, further optimising the triage process. Wait times for patients with acute IA were also reduced with development of rapid access systems. CONCLUSIONS: This review identified three main areas of delay to care for patients with IA and potential solutions for each. A co-ordinated effort will be required by the rheumatology and primary care community to address these effectively.
BACKGROUND: Despite the importance of timely management of patients with inflammatory arthritis (IA), delays exist in its diagnosis and treatment. OBJECTIVE: To perform a systematic literature review to identify strategies addressing these delays to inform an American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) taskforce. METHODS: The authors searched literature published between January 1985 and November 2010, and ACR and EULAR abstracts between 2007-2010. Additional information was obtained through a grey literature search, a survey conducted through ACR and EULAR, and a hand search of the literature. RESULTS: (1) From symptom onset to primary care, community case-finding strategies, including the use of a questionnaire and autoantibody testing, have been designed to identify patients with early IA. Several websites provided information on IA but were of varying quality and insufficient to aid early referral. (2) At a primary care level, education programmes and patient self-administered questionnaires identified patients with potential IA for referral to rheumatology. Many guidelines emphasised the need for early referral with one providing specific referral criteria. (3) Once referred, early arthritis clinics provided a point of early access for rheumatology assessment. Triage systems, including triage clinics, helped prioritise clinic appointments for patients with IA. Use of referral forms standardised information required, further optimising the triage process. Wait times for patients with acute IA were also reduced with development of rapid access systems. CONCLUSIONS: This review identified three main areas of delay to care for patients with IA and potential solutions for each. A co-ordinated effort will be required by the rheumatology and primary care community to address these effectively.
Authors: Franziska Fuchs; Harriet Morf; Jacob Mohn; Felix Mühlensiepen; Yuriy Ignatyev; Daniela Bohr; Elizabeth Araujo; Christina Bergmann; David Simon; Arnd Kleyer; Wolfgang Vorbrüggen; Andreas Ramming; Jörg H W Distler; Peter Bartz-Bazzanella; Georg Schett; Martin Welcker; Axel J Hueber; Johannes Knitza Journal: Rheumatol Int Date: 2022-10-10 Impact factor: 3.580
Authors: Rachel Knevel; Johannes Knitza; Aase Hensvold; Alexandra Circiumaru; Tor Bruce; Sebastian Evans; Tjardo Maarseveen; Marc Maurits; Liesbeth Beaart-van de Voorde; David Simon; Arnd Kleyer; Martina Johannesson; Georg Schett; Tom Huizinga; Sofia Svanteson; Alexandra Lindfors; Lars Klareskog; Anca Catrina Journal: Front Med (Lausanne) Date: 2022-04-25
Authors: Elizabeth W Karlson; Dirkjan van Schaardenburg; Annette H van der Helm-van Mil Journal: Rheumatology (Oxford) Date: 2014-08-04 Impact factor: 7.580
Authors: Cheryl Barnabe; Juan Xiong; Janet E Pope; Gilles Boire; Carol Hitchon; Boulos Haraoui; J Carter Thorne; Diane Tin; Edward C Keystone; Vivian P Bykerk Journal: Rheumatol Int Date: 2013-08-30 Impact factor: 2.631
Authors: Beth I Wallace; Paul Lin; Neil Kamdar; Mohamed Noureldin; Rodney Hayward; David A Fox; Jeffrey R Curtis; Kenneth G Saag; Akbar K Waljee Journal: Semin Arthritis Rheum Date: 2019-09-07 Impact factor: 5.532
Authors: Rebecca J Stack; Christian D Mallen; Chris Deighton; Patrick Kiely; Karen L Shaw; Alison Booth; Kanta Kumar; Susan Thomas; Ian Rowan; Rob Horne; Peter Nightingale; Sandy Herron-Marx; Clare Jinks; Karim Raza Journal: Health Expect Date: 2014-06-03 Impact factor: 3.377